Sign in

CIK 0001034842 · Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943248524
Phone
650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-02 Schorno Dean L EVP & Chief Financial Officer Option exercise +694 $12.70 $9K 79,056
2026-09-02 Schorno Dean L EVP & Chief Financial Officer Option exercise +620 $18.70 $12K 79,676
2026-09-02 Schorno Dean L EVP & Chief Financial Officer Option exercise +2,000 $24.20 $48K 81,676
2026-09-02 Schorno Dean L EVP & Chief Financial Officer Option exercise +1,286 $24.20 $31K 82,962
2026-09-02 Schorno Dean L EVP & Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −694 12,824
2026-09-02 Schorno Dean L EVP & Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −620 9,012
2026-09-02 Schorno Dean L EVP & Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −2,000 7,999
2026-09-02 Schorno Dean L EVP & Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −1,286 15,867
2026-09-01 Schorno Dean L EVP & Chief Financial Officer Shares withheld for taxes −928 $47.50 $44K 78,362
2026-09-01 Santos David A EVP, Chief Commercial Officer Shares withheld for taxes −874 $47.50 $42K 61,622
2026-09-01 RODRIGUEZ RAUL R CEO, President Shares withheld for taxes −2,424 $47.50 $115K 273,362
2026-09-01 Furey Raymond J. EVP, GC, CCO & Corp Sec Shares withheld for taxes −877 $47.50 $42K 50,559
2026-07-08 HANNAH ALISON L. EVP, Chief Medical Officer Grant or award +24,400 35,025
2026-06-22 Ali-Jackson Kamil Director Sale 10b5-1 −2,500 $35.00 $88K 10,125
2026-06-17 Rojkjaer Lisa EVP, Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +9,375 9,375
2026-06-17 Rojkjaer Lisa EVP, Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +7,394 7,394
2026-06-17 Furey Raymond J. EVP, GC, CCO & Corp Sec Grant or award · Employee Stock Option (right to buy) +7,394 7,394
2026-06-17 RODRIGUEZ RAUL R CEO, President Grant or award · Employee Stock Option (right to buy) +31,700 31,700
2026-06-17 Santos David A EVP, Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +7,394 7,394
2026-06-17 Schorno Dean L EVP & Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +7,394 7,394

Page 1 of 9 · 176 trades